Nanobiotix S.A. ADR Company Profile
NASDAQ: NBTXHealth CareBiotechnology: Pharmaceutical PreparationsUSD
Market open · Delayed 15 min · as of Oct 9, 9:32 AM ET
Nanobiotix S.A. at a glance
Nanobiotix S.A. ADR (NASDAQ: NBTX) is a Biotechnology: Pharmaceutical Preparations company in the Health Care sector headquartered in Paris, France. Nanobiotix S.A. is led by Dr. Laurent Levy Ph.D. and employs about 100 people. The company's shares have traded publicly since 2020.
At a market capitalization of $1.17 billion, it is considered a small-cap company. Its SEC Central Index Key (CIK) is 0001760854, which identifies the company's filings on EDGAR.
Summary generated from market data by MetaCap's automated system. Methodology
What does Nanobiotix S.A. do?
Nanobiotix S.A. operates as a clinical-stage biotechnology that focuses on developing product candidates for the treatment of cancer and other unmet medical needs. Its lead product candidate is NBTXR3, a sterile aqueous suspension of crystalline hafnium oxide nanoparticles used for the treatment of soft tissue sarcoma, head and neck, liver, prostate, pancreatic, esophageal, rectal, and non-small cell lung cancer. The company has a partnership with Lian Oncology Limited to develop and commercialize NBTXR3 in China, South Korea, Singapore, and Thailand. Nanobiotix S.A. was incorporated in 2003 and is based in Paris, France.
Business description based on the company's public filings.
Company information
- Legal name
- Nanobiotix S.A. ADR
- Ticker
- NASDAQ: NBTX
- Sector
- Health Care
- Industry
- Biotechnology: Pharmaceutical Preparations
- CEO
- Dr. Laurent Levy Ph.D.
- Employees
- 100
- Headquarters
- 60 rue de Wattignies, Paris, France
- Phone
- 33 1 40 26 04 70
- Website
- nanobiotix.com
- IPO year
- 2020
- Market cap
- $1.17B
- SEC CIK
- 0001760854
Companies similar to Nanobiotix S.A.
| Company | Price | % Chg | Market cap | Compare |
|---|---|---|---|---|
| LBRXLB Pharmaceuticals Inc | 36.17 | +4.51% | $1.17B | vs NBTX |
| JANXJanux Therapeutics Inc. | 18.74 | +1.30% | $1.15B | vs NBTX |
| TRAXFirst Tracks Biotherapeutics Inc. | 31.94 | -0.23% | $1.14B | vs NBTX |
| AVLNAvalyn Pharma Inc. | 25.70 | -0.08% | $1.14B | vs NBTX |
| BCAXBicara Therapeutics Inc. | 17.18 | -0.46% | $1.14B | vs NBTX |
| HROWHarrow Inc. | 29.80 | -2.36% | $1.12B | vs NBTX |
| AMPHAmphastar Pharmaceuticals Inc. | 25.86 | +0.19% | $1.10B | vs NBTX |
| ORICOric Pharmaceuticals Inc. | 11.90 | -1.08% | $1.23B | vs NBTX |